MaxCyte 2025 Financial Results Review
MaxCyte, Inc. (MXCT) posted a Q4 2025 GAAP loss of $0.09 per share, wider than the -$0.08 expected loss (10.3% wider).
7 articles, transcripts, and reports
MaxCyte, Inc. (MXCT) posted a Q4 2025 GAAP loss of $0.09 per share, wider than the -$0.08 expected loss (10.3% wider).
MaxCyte Inc (NASDAQ: MXCT) Q3 2022 Earnings Conference
MaxCyte Inc (NASDAQ: MXCT) Q2 2022 Earnings Conference
MaxCyte Inc (NASDAQ: MXCT) Q1 2022 Earnings Conference
MaxCyte Inc (NASDAQ: MXCT) Q4 2021 Earnings Conference
MaxCyte Inc (NASDAQ: MXCT) Q3 2021 Earnings Conference
MaxCyte Inc (NASDAQ: MXCT) Q2 2021 Earnings Conference